Select Your Language:

Advancing Rare Disease Equity Requires All of Us

The global rare disease community faces many challenges, including access to diagnosis, appropriate care and treatment, resources, and broader representation. In 2022, #RAREis launched #RAREis Representation, a program to address the global unmet need for diversity, equity, inclusion and allyship in rare disease.

Through #RAREis Representation, we will be sharing diverse stories, hosting community conversations around advancing global equity in rare disease, and taking action to support people in the rare disease community. According to the World Health Organization, approximately 400 million people globally are impacted by a rare disease. Advancing rare disease equity requires all of us to do our part.

Watch More

Add Your Voice and Provide Feedback to Key Issues

We want to hear from you. Answer the below questions to address key issues surrounding diversity, equity, inclusion and allyship in the global rare disease community.

"*" indicates required fields

You are Leaving

You are now leaving the #RAREis™ Community website. Amgen is not responsible for content or availability of third-party sites.

Return to OK, Continue X